Dey's Medical Stores (Manufacturing) Limited, commonly known as Dey's, is a well-established pharmaceutical company in India. Founded in 1986, the company specializes in the manufacture of essential and life-saving drugs, including antibiotics and various therapeutic segments such as ophthalmic and gastrointestinal products. Dey's has a significant presence in both domestic and international markets. Recent Developments Dey's Medical has a robust distribution network with over 1,550 stockists and is known for its commitment to quality and customer-centric approach. The company has expanded its product range to include various therapeutic segments, and it is recognized for its brands like I-Tone and Milk of Magnesia. Business Operations Dey's Medical Stores focuses on manufacturing a wide range of pharmaceutical products, including: Antibiotics Ophthalmic preparations Gastrointestinal medications Herbal preparations The company operates multiple manufacturing facilities compliant with GMP (Good Manufacturing Practices) standards, ensuring high-quality production processes. Investment Considerations Market Position: Dey's Medical holds a strong position in the Indian pharmaceutical market with a diverse product portfolio. Growth Potential: The increasing demand for pharmaceuticals in India provides significant growth opportunities for Dey's. Financial Stability: While specific financial metrics are not provided, the company's long-standing presence and established brands suggest a solid operational foundation. Liquidity Risk: As an unlisted entity, shares may have lower liquidity compared to listed companies, which can affect the ease of buying and selling shares. Future Listing Possibilities: Investors may consider the potential for future public listing, which could enhance liquidity and provide an exit strategy.
P&L Statement | 2019 | 2020 | 2021 |
---|---|---|---|
Revenue | 10521 | 10901 | 11011 |
Cost of Material Consumed | 3847 | 3931 | 3468 |
Gross Margins | 63.44 | 63.94 | 68.5 |
Change in Inventory | -74 | -84 | 158 |
Employee Benefit Expenses | 3346 | 3683 | 3867 |
Other Expenses | 2438 | 2505 | 2183 |
EBITDA | 964 | 866 | 1335 |
OPM | 9.16 | 7.94 | 12.12 |
Other Income | 102 | 154 | 201 |
Finance Cost | 11 | 15 | 13 |
D&A | 65 | 62 | 70 |
EBIT | 899 | 804 | 1265 |
EBIT Margins | 8.54 | 7.38 | 11.49 |
PBT | 990 | 943 | 1453 |
PBT Margins | 9.41 | 8.65 | 13.2 |
Tax (2021) | 303 | 243 | 391 |
PAT | 687 | 700 | 1062 |
NPM | 6.53 | 6.42 | 9.64 |
EPS | 80.71 | 82.24 | 124.77 |
Financial Ratios | 2019 | 2020 | 2021 |
---|---|---|---|
Operating Profit Margin | 9.16 | 7.94 | 12.12 |
Net Profit Margin | 6.53 | 6.42 | 9.64 |
Earning Per Share (Diluted) | 80.71 | 82.24 | 124.77 |
Assets | 2019 | 2020 | 2021 |
---|---|---|---|
Fixed Assets | 511 | 581 | 577 |
CWIP | 0 | 0 | 0 |
Investments | 0 | 0 | 0 |
Trade Receivables | 1026 | 1162 | 1324 |
Inventory | 2245 | 2356 | 2149 |
Other Assets | 3481 | 4048 | 5612 |
Total Assets | 7263 | 8147 | 9662 |
Liabilities | 2019 | 2020 | 2021 |
---|---|---|---|
Share Capital | 85.12 | 85.12 | 85.12 |
FV | 10 | 10 | 10 |
Reserves | 5259 | 5946 | 6987 |
Borrowings | 209 | 208 | 240 |
Trade Payables | 628 | 570 | 359 |
Other Liabilities | 1081.88 | 1337.88 | 1990.88 |
Total Liabilities | 7263 | 8147 | 9662 |
Cash-Flow Statement | 2019 | 2020 | 2021 |
---|---|---|---|
PBT | 989 | 942 | 1452 |
OPBWC | 963 | 868 | 1335 |
Change in Receivables | -194 | -79 | -339 |
Change in Inventories | -38 | -111 | 206 |
Change in Payables | 171 | -19 | 25 |
Other Changes | 0 | 0 | 0 |
Working Capital Change | -61 | -209 | -108 |
Cash Generated From Operations | 902 | 659 | 1227 |
Tax | -167 | -283 | -222 |
Cash Flow From Operations | 735 | 376 | 1005 |
Purchase of PPE | -24 | -135 | -70 |
Sale of PPE | 0 | 0 | 0 |
Cash Flow From Investment | 78 | 16 | 130 |
Borrowing | 672 | 173 | 753 |
Divided | 8 | 13 | 8 |
Equity | 0 | 0 | 0 |
Others From Financing | -1373 | -390 | -1535 |
Cash Flow from Financing | -693 | -204 | -774 |
Net Cash Generated | 120 | 188 | 361 |
Cash at the Start | 1022 | 1142 | 1331 |
Cash at the End | 1142 | 1330 | 1692 |
Shareholding Pattern | 2019 | 2020 | 2021 |
---|---|---|---|
Promoters | 98.36% | 98.36% | 98.36% |
Insurance Companies | 0.92% | 0.92% | 0.92% |
Individual Investors | 0.72% | 0.72% | 0.72% |